Bench to bedside: episode 4 - "from biomarker to surrogate"

BIA’s Science and Innovation Advisory Committee (SIAC) are delivering a series of webinars in 2019 titled ‘Bench to Bedside’. The content has been proposed by industry and will explore the drug discovery process from discovery to delivery. The series will be concluded with a panel session at our UK Bioscience Forum on 17 October.

This session will discuss the types of biomarker used in preclinical and clinical development and considers the factors leading to biomarker qualification as well as steps which may lead to approval of the marker as a surrogate endpoint for drug approval.

Speaker

Dr Penny Ward

Dr Penny Ward

Director, PWG Consulting Ltd

Next episodes 2019:

Concluding session - UK Bioscience Forum, 17 October, London

 

Media Supporters

Clinical prof logo.png

Thank you Clinical Professionals

 

 

BIA Annual Supporters